Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)
Crossref DOI link: https://doi.org/10.1007/s00240-023-01455-1
Published Online: 2023-06-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goldfarb, David S. http://orcid.org/0000-0002-9215-1273
Lieske, John C.
Groothoff, Jaap
Schalk, Gesa
Russell, Kerry
Yu, Shuli
Vrhnjak, Blaz
Text and Data Mining valid from 2023-06-05
Version of Record valid from 2023-06-05
Article History
First Online: 5 June 2023